Nootropic Peptides in Australia: Semax, Selank and Cognitive Research

Nootropic peptides are short amino acid chains that interact with neurobiological pathways involved in cognition, memory, mood, and neuroprotection. Unlike small-molecule nootropics (racetams, modafinil), peptides act via receptor-mediated signalling and gene expression changes rather than direct receptor binding, which gives them a distinct pharmacological profile.

The most extensively researched nootropic peptides currently available from Australian suppliers are Semax and Selank, both developed in Russia and both with published clinical investigation histories unusual for research peptides.

Semax is a synthetic heptapeptide derived from the ACTH 4–7 sequence. Its most significant research mechanism is BDNF (Brain-Derived Neurotrophic Factor) upregulation, BDNF is essential for synaptic plasticity, neuronal survival, and long-term memory consolidation.

Key research findings for Semax:

• Increases BDNF and NGF (Nerve Growth Factor) expression in hippocampal and cortical tissue in rodent models
• Improves performance on spatial learning and working memory tasks in animal models of cognitive impairment
• Approved in Russia for cognitive disorders and ischaemic stroke, clinical trial data exists, though Western independent replication is limited
• Dopaminergic and serotonergic modulatory effects contribute to its activating, focus-oriented profile
• Anti-inflammatory CNS effects observed in models of neuroinflammation

In research models, Semax is characterised as stimulating and focus-enhancing rather than sedating. Researchers studying attention, executive function, or neuroprotection typically investigate Semax first in this class.

Selank is a synthetic analogue of the naturally occurring immunopeptide tuftsin, with the sequence Thr-Lys-Pro-Arg-Pro-Gly-Pro. It was developed at the Institute of Molecular Genetics (Russia) alongside Semax, but its research profile is primarily anxiolytic rather than activating.

Key research findings for Selank:

• GABAergic modulation, Selank enhances the effect of GABA-A receptor ligands without direct binding; this contributes to its anxiolytic profile without the sedation or dependence associated with benzodiazepines in animal models
• Serotonin metabolism modulation, studies report Selank increases serotonin turnover in brain tissue, contributing to mood stabilisation effects in animal models
• Enkephalin stabilisation, Selank inhibits enkephalin-degrading enzymes, elevating endogenous opioid peptide levels; proposed as part of its anxiolytic mechanism
• Approved in Russia for anxiety disorders and as an anxiolytic with nootropic properties
• Immune modulation, tuftsin-derived structure gives Selank immunotropic effects; research includes IL-6 modulation and T-cell activity

Selank is the preferred choice for researchers studying anxiety, stress response, and mood regulation without the confounding sedation of classical anxiolytics.

The two peptides are complementary rather than competing:

• Primary effect direction: Semax is activating; Selank is calming
• Main research applications: Semax for cognition/neuroprotection; Selank for anxiety/mood
• Mechanism distinction: Semax via BDNF/NGF; Selank via GABA/serotonin/enkephalin
• Administration: Both can be administered subcutaneously or intranasally in research models

Some research protocols investigate both compounds in combination to study complementary cognitive and anxiolytic effects simultaneously.

Beyond Semax and Selank, several other peptides available from OzPeps have research profiles relevant to cognitive and neurological function:

• DSIP (Delta Sleep-Inducing Peptide), nonapeptide with research interest in sleep architecture and HPA axis regulation; sleep quality is directly relevant to cognitive performance research
• MOTS-c, mitochondrial peptide with AMPK activation; cognitive research increasingly focuses on mitochondrial bioenergetics as a driver of brain function
• Epithalon, telomerase activation and pineal peptide; neuroprotective and circadian regulation research overlap with cognitive ageing models

OzPeps is one of the few Australian suppliers stocking both Semax and Selank, neither Peptide Paradise nor Lazarus Labs currently carry these compounds. Browse the full nootropic peptide range:

• Semax 10mg →
• Selank 10mg →
• DSIP 10mg →
• Epithalon 10mg →

All nootropic peptides supplied by OzPeps are for laboratory and in-vitro research purposes only. They are not TGA-approved therapeutic goods and are not intended for human or animal consumption. Researchers are responsible for compliance with all applicable regulations.